Drug Utilization Research: Methods and Applications

Drug Utilization Research: Methods and Applications

Drug Utilization Research: Methods and Applications

Drug Utilization Research: Methods and Applications

eBook

$138.00 

Available on Compatible NOOK Devices and the free NOOK Apps.
WANT A NOOK?  Explore Now

Related collections and offers

LEND ME® See Details

Overview

Drug Utilization Research (DUR) is an eclectic scientific discipline, integrating descriptive and analytical methods for the quantification, understanding and evaluation of the processes of prescribing, dispensing and consumption of medicines and for the testing of interventions to enhance the quality of these processes. The discipline is closely related and linked mainly to the broader field of pharmacoepidemiology, but also to health outcomes research, pharmacovigilance and health economics.

Drug Utilization Research is a unique, practical guide to the assessment and evaluation of prescribing practices and to interventions to improve the use of medicines in populations. Edited by an international expert team from the International Society for Pharmacoepidemiology (ISPE), DUR is the only title to cover both the methodology and applications of drug utilization research and covers areas such as health policy, specific populations, therapeutics and adherence.


Product Details

ISBN-13: 9781118949771
Publisher: Wiley
Publication date: 04/01/2016
Sold by: JOHN WILEY & SONS
Format: eBook
Pages: 536
File size: 7 MB

About the Author

Monique Elseviers, Centre for Research and Innovation in Care, University of Antwerp, Belgium.

Björn Wettermark, Associate Professor in Pharmacoepidemiology, Karolinska Institutet, Stockholm, Sweden.

Morten Andersen, Visiting Professor, Centre for Pharmacoepidemiology, Karolinska Institutet, Stockholm, Sweden; Senior Physician at the Department of Clinical Pharmacology, Karolinska University Hospital, Stockholm, Sweden; Senior Researcher at the Research Unit for General Practice, University of Southern Denmark, Denmark.

Ria Benko, Associate Professor, Department of Clinical Pharmacy at the University of Szeged, Hungary.

Marion Bennie, Professor of Pharmacy Practice, University of Strathclyde, UK; Chief Pharmaceutical Adviser, NHS National Services Scotland, UK.

Brian Godman, Research Scientist, Karolinska Institutet, Stockholm, Sweden.

Janet Krska, Professor of Clinical and Professional Pharmacy, Medway School of Pharmacy, Universities of Greenwich and Kent, UK.

Elisabetta Poluzzi, Assistant Professor of Pharmacology, Department of Pharmacology, Faculty of Medicine, University of Bologna, Italy.

Katja Taxis, Associate Professor of Pharmacotherapy and Clinical Pharmacy, University of Groningen, Netherlands.

Vera Vlahovic-Palcevski, Professor, Department of Pharmacology, University of Rijeka Medical School, Croatia; Specialist in Clinical Pharmacology, University Hospital Rijeka, Croatia.

Robert Vander Stichele, practicing family physician in Ghent, Belgium.

Table of Contents

List of contributors viii

Acknowledgements xiv

About the companion website xix

Part 1 Introduction

1 Introduction to drug utilization research 3
Björn Wettermark, Monique Elseviers, Anna Birna  Almarsdóttir, Morten Andersen, Ria Benko, Marion Bennie, Irene Eriksson, Brian Godman, Janet Krska, Elisabetta Poluzzi, Katja Taxis, Robert Vander Stichele, Vera Vlahovic-Palcevski

Part 2 Methodology

2 Study designs in drug utilization research 15
Björn Wettermark, Mirko Di Martino, Monique Elseviers

3 Primary data collection for drug utilization research 29
Tatiana Chama Borges Luz, Evalill Nilsson

4 Secondary data sources for drug utilization research 39
Irene Eriksson, Luisa Ibáñez

5 Classifi cation systems for drugs and diseases 49
Marit Rønning, Stuart McTaggart

6 Measurement units of drug utilization 58
Hege Salvesen Blix

7 Individual-level drug utilization analyses 68
Jesper Hallas, Henrik Støvring, Anton Pottegård

8 Measurement of drug expenditure 77
Sabine Vogler, Jaana E. Martikainen

9 Basic statistical methods in drug utilization research 88
Douglas T. Steinke, Monique Elseviers

10 Visualization of drug utilization data 99
Maria Matuz, Ria Benko, Mikael Hoffmann

11 Multilevel analyses in drug utilization research 116
Juan Merlo

12 Defi ning and developing quality indicators for drug utilization 126
Stephen Campbell, Björn Wettermark, Morten Andersen

13 Qualitative methods in drug utilization research 139
Anna Birna Almarsdóttir, Pia Bastholm Rahmner

Part 3 Applied drug utilization research

Section A Comparative drug utilization research

14 Comparison of drug utilization across different geographical areas 153
Vera Vlahovic-Palcevski, Björn Wettermark, Luisa Ibáñez, Robert Vander Stichele

15 Comparison of drug utilization in different health care settings 160
Sean MacBride-Stewart, Ksenia Zagorodnikova, Irene Langner, Gisbert W. Selke

16 Time-dependent and seasonal variations in drug utilization 173
Eric Van Ganse, Laurent Laforest, Niels Adriaenssens

17 Comparative studies of patient and prescriber characteristics 184
Irene Eriksson, Ulf Bergman, Vera Vlahovic-Palcevski, Mia von Euler

18 Comparative studies of health systems 194
Tatiana Chama Borges Luz, Claudia Garcia Serpa Osorio-de-Castro, Björn Wettermark

Section B Drug utilization and health policy

19 Drug utilization and health policy 203
Brian Godman, Hye Young Kwon, Marion Bennie, Anna Birna Almarsdóttir

20 Managed introduction of new drugs 210
Brian Godman, Roberta Joppi, Marion Bennie, Saira Jan, Björn Wettermark

21 Management of drugs in the health care system 222
Brian Godman, Marion Bennie, Claudia Garcia Serpa Osorio‐de‐Castro, Vu Thi Thu Huong, Saira Jan

22 The pharmaceutical industry and health policy 231
Richard Torbett, Donald Han, Indranil Bagchi

Section C Drug utilization in specific populations

23 Drug utilization in pregnant women 240
Hedvig Nordeng

24 Drug utilization in the paediatric population 248
Antje Neubert, Katja Taxis, Ian C.K. Wong

25 Drug utilization in older people 259
Katja Taxis, David O’Sullivan, Shane Cullinan, Stephen Byrne

Section D Drug utilization in specific therapeutic areas

26 Drug utilization research in the area of antibiotics 270
Ria Benko, Marion Bennie, Samuel Coenen

27 Drug utilization research in the area of cardiovascular medicines 284
Elisabetta Poluzzi, Maarit Jaana Korhonen

28 Drug utilization research in the area of analgesics and psychotropics 294
Helga Zoëga, Alesha Smith, Nadia Barozzi

29 Drug utilization research in the area of biologicals 302
Carlo Piccinni, Luigi Naldi, Martin Neovius

30 Drug utilization research in the area of cancer drugs 315
Nils Wilking, Thomas Hofmarcher, Ulla Wilking, Bengt Jönsson

Section E Determinants of drug utilization

31 Health system perspectives 328
Paul Spivey, Brian Godman

32 Prescriber perspectives 336
Colin Bradley, Kathleen Holloway, Janet Krska

33 Patient perspectives 347
Janine Traulsen, Nicky Britten, Janet Krska

Section F Adherence and drug utilization research

34 An introduction to adherence research 355
Bernard Vrijens

35 Assessment of medication adherence in field research 361
Monique Elseviers, Bernard Vrijens

36 Assessment of adherence to drug treatment in database research 369
Jean-Pierre Grégoire, Jocelyne Moisan

37 Interventions to improve adherence to drug treatment 381
Marie-Paule Schneider, Jennifer Celio, Yoleen van Camp, Matthias Cavassini

Section G The role of drug utilization within the field of pharmacoepidemiology

38 Drug utilization research and risk management 392
Giampiero Mazzaglia, Peter Mol

39 Drug utilization research and pharmacovigilance 399
Emanuel Raschi, Fabrizio De Ponti

40 Drug utilization research and the regulator’s perspective in pharmacovigilance 408
Xavier Kurz, Kevin Blake

41 Drug utilization research and outcomes research 417
Henrik Toft Sørensen, Gianluca Trifi rò

42 Drug utilization research and pharmacoeconomics 425
Cara Usher, Kathleen Bennett, Lorenzo G. Mantovani, Dyfrig Hughes

Section H Assessment and improvement of the quality of medicine use

43 Assessment of quality of prescribing using quality indicators 433
Petra Denig, Flora Haaijer-Ruskamp, Lisa Pont

44 Quality indicators for patient care in pharmacy practice 443
Hanne Herborg

45 Interventions that infl uence prescribing decisions and drug utilization 460
Jens Søndergaard, Dorte Gilså Hansen, Debra Rowett

46 Development, delivery and evaluation of implementation programmes 468
Elizabeth Roughead, Andrew Gilbert

47 Towards a better understanding of prescribingenhancement interventions 477
Frank May

Part 4 Epilogue

48 The many futures of drug utilization research 489
Hubert G.M. Leufkens, Frank May, Nicky Britten

Glossary 492

Index 497

From the B&N Reads Blog

Customer Reviews